Co-Diagnostics CODX Cash Flow Statement (2016-2026)

NASDAQ CODX
$0.26 -0.01 (-3.70%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Co-Diagnostics Quarterly Cash Flow Statement

Periods 42 quarters
Latest Sep 2026

Co-Diagnostics reported cash from operations of -$5.68M and free cash flow of -$5.70M for the quarter ended Sep 2026, up 3.7% year over year. This cash flow statement covers 42 quarters of results from Jun 2016 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
7.50M11.71M-2.69M-1.36M-21.91M-5.76M-8.92M-5.98M-14.68M-9.31M-7.60M-9.70M-11.03M-7.53M-7.73M-5.89M-25.75M-9.14M-6.28M-6.31M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.10M0.25M0.42M0.31M0.30M0.32M0.31M0.30M0.31M0.33M0.34M0.35M0.36M0.28M0.29M0.27M0.27M0.26M0.20M0.22M
Share-based CompensationStock Comp.
1.66M1.38M1.53M2.23M2.40M2.17M2.17M2.17M1.83M1.57M1.50M1.05M1.32M0.88M0.58M0.50M0.29M0.22M0.21M0.26M
Deferred Taxes
0.90M-1.36M-0.56M-1.51M-1.38M-2.21M-2.22M-2.26M4.27M
Gains from Equity InvestmentsGains Equity
0.03M
Gains from Sales and DivestituresGains Divest
-0.09M-0.05M0.00M0.00M0.00M0.00M0.00M-0.01M0.00M-0.08M
Gains from Investment SecuritiesGains Investment
-0.03M-0.02M-0.11M-0.13M-0.08M0.42M0.41M0.43M0.99M0.23M-0.07M0.29M0.28M0.30M0.34M-0.06M-0.01M-0.05M-0.10M
Asset Writedowns and ImpairmentWritedown
0.20M0.24M0.05M2.74M0.05M0.04M0.08M0.16M-0.04M-0.06M-0.04M19.02M-0.03M-0.03M-0.01M
Other non-cash itemsOther Non-Cash
-0.09M0.06M-0.03M0.33M2.14M-0.11M0.62M0.02M0.12M-0.01M-0.02M0.05M-0.01M438.000.00M0.00M0.00M0.00M0.00M0.00M
Non-cash ItemsNon-Cash Items
Change in Working Capital
Change in ReceivablesChange Receivables
6.13M0.87M-9.44M-3.97M-2.38M-0.87M-1.00M-0.28M-0.39M0.12M0.09M-0.32M-0.07M0.01M0.06M-0.16M0.13M-0.10M-0.03M0.00M
Change in InventoryChange Inventory
-1.27M3.09M-0.17M0.74M0.02M0.18M-0.36M-0.12M-0.12M-0.07M-0.05M-0.12M-0.03M-0.03M-0.06M-0.04M-0.01M-0.17M-0.04M-0.18M
Change in Accrued ExpensesChange Accrued Exp.
-0.38M-0.64M-1.06M0.90M-1.68M0.44M1.02M-0.10M0.41M-0.30M-0.02M0.61M1.87M-1.55M-1.66M0.02M0.08M0.64M-1.41M-0.19M
Change in TaxesChange Taxes
1.95M2.75M-4.66M0.10M-0.38M0.01M0.01M0.16M-0.70M0.02M0.02M0.02M-0.01M0.01M0.01M-0.25M-0.49M
Change in Other Operating AssetsOther Assets Change
1.93M-1.04M0.25M0.35M0.67M-0.06M-0.19M0.10M-0.93M0.13M-0.43M-0.33M0.22M-0.21M-0.48M0.76M-0.66M0.00M0.03M-0.15M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.04M-0.15M0.02M0.24M0.09M0.01M-0.06M-0.09M-0.16M-0.02M-300.00-0.03M-0.01M0.03M-0.03M
Other Working Capital ChangesOther WC Changes
-1.97M0.89M-0.25M-0.35M-0.67M0.08M0.43M0.00M0.94M-0.18M0.34M0.17M-0.23M0.21M0.48M-0.76M0.62M-0.01M0.00M0.12M
Other Operating Activities (as filed)
Cash from OperationsCash from Ops.
4.88M7.81M1.65M1.12M-4.01M-5.92M-5.62M-5.77M-4.78M-8.49M-5.20M-7.23M-8.23M-8.75M-8.29M-5.90M-6.20M-7.85M-7.15M-5.68M
Investing Activities
Capital ExpendituresCapex
0.12M0.40M0.51M0.23M0.29M0.18M0.48M0.24M0.46M0.40M0.10M0.17M0.07M0.09M0.40M0.08M0.13M0.14M0.17M0.02M
Change in Property, Plant and EquipmentChange in PP&E
-0.12M-0.40M-0.51M-0.23M-0.29M-0.18M-0.48M-0.24M-0.46M-0.40M-0.10M-0.17M-0.07M-0.09M-0.40M-0.08M-0.13M-0.14M-0.17M-0.02M
Purchase of InvestmentsInvestments Purchased
-726.0058.05M40.57M24.72M18.31M26.89M0.31M13.39M13.85M13.39M6.44M0.14M0.00M0.10M
Sale and Maturity of InvestmentsInvestments Sold
0.00M1.26M4.97M5.03M30.54M38.85M20.89M36.97M17.38M9.45M18.20M13.73M13.89M17.62M2.25M-0.09M
Cash from Investing ActivitiesCash from Investing
1.07M0.86M-10.46M4.74M-53.31M-10.21M13.65M2.34M9.62M16.67M-4.04M4.17M0.27M7.36M17.07M2.17M-0.33M-0.14M-0.17M-0.02M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Net Long-Term Debt Issued (Repaid)Net LT Debt
Short-Term Debt issuancesST Debt Issuance
Short-Term Debt repaymentsST Debt Repayment
Net Short-Term Debt Issued (Repaid)Net ST Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
0.15M0.03M-1.000.35M0.43M2.74M-1.70M4.33M-1.59M2.44M
Shares Repurchased
10.39M1.22M0.48M0.56M0.17M0.16M
Net Shares Issued and RepurchasedNet Shares Issued
0.15M0.03M-10.39M-1.22M-0.48M-0.56M-0.17M-0.16M0.35M0.43M2.74M-1.70M4.33M-1.59M2.44M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.15M0.03M-10.39M-1.22M-0.48M-0.56M-0.17M-0.16M0.35M0.43M2.74M-1.70M4.33M-1.59M2.44M
Other financing activities (as filed)
Cash from Financing ActivitiesCash from Financing
0.15M-2.57M-10.39M-1.22M-0.48M-0.56M-0.17M-0.16M0.35M0.43M4.06M6.97M4.33M2.74M2.76M
Additional items
Change in Cash
5.95M8.81M-11.38M-4.54M-58.53M-16.61M7.47M-3.59M4.68M8.18M-9.24M-3.06M-7.86M-1.03M9.21M0.33M0.44M-3.65M-4.58M-2.93M
Beginning Cash Balance
Ending Cash Balance
88.61M97.42M86.05M81.51M22.97M6.36M13.83M10.24M14.92M23.10M13.86M10.80M2.94M1.90M11.12M11.44M11.88M8.23M3.65M0.71M
Free Cash FlowFCF
4.76M7.41M1.15M0.89M-4.30M-6.10M-6.10M-6.00M-5.24M-8.89M-5.30M-7.40M-8.30M-8.84M-8.69M-5.98M-6.33M-7.99M-7.32M-5.70M
Net Cash FlowNCF
5.95M8.81M-11.38M-4.54M-58.53M-16.61M7.47M-3.59M4.68M8.18M-9.24M-3.06M-7.97M-1.03M9.21M0.33M0.44M-3.65M-4.58M-2.93M
Interest Paid
Income Taxes PaidTaxes Paid
0.67M-0.04M0.00M0.03M0.02M0.01M-0.02M-0.86M0.05M-0.02M

Co-Diagnostics Cash Flow Statement API

Pull Co-Diagnostics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CODX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY